FEMY
Price
$1.50Alerts
Change
+$0.07 (+4.90%)
Updated
Nov 11 closing price
Capitalization
11.47M
2 days until earnings call
Intraday BUY SELL Signals
LUCD
Price
$0.38Alerts
Change
-$0.02 (-5.00%)
Updated
Nov 11 closing price
Capitalization
76M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FEMY vs LUCD

FEMY vs LUCD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
FEMY vs. LUCD commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEMY is a Buy and LUCD is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for FEMY with price predictions
Nov 10, 2026

FEMY's RSI Oscillator ascends from oversold territory

The RSI Indicator for FEMY moved out of oversold territory on November 03, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 40 similar instances when the indicator left oversold territory. In 40 of the 40 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 73 cases where FEMY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on FEMY as a result. In 83 of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.

The Moving Average Convergence Divergence (MACD) for FEMY just turned positive on November 02, 2026. Looking at past instances where FEMY's MACD turned positive, the stock continued to rise in 37 of 41 cases over the following month. The odds of a continued upward trend are 90%.

Following a +4.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where FEMY advanced for three days, in 143 of 179 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

FEMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FEMY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for FEMY entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.846) is normal, around the industry mean (4.964). P/E Ratio (-0.504) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.324) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. FEMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FEMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for LUCD with price predictions
Nov 10, 2026

LUCD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for LUCD turned positive on October 27, 2026. Looking at past instances where LUCD's MACD turned positive, the stock continued to rise in 43 of 47 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where LUCD's RSI Oscillator exited the oversold zone, 31 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +7.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where LUCD advanced for three days, in 199 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

LUCD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LUCD as a result. In 75 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for LUCD entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.955) is normal, around the industry mean (4.142). P/E Ratio (-0.971) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (21.645) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. LUCD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
FEMYLUCD
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 15 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (FEMY: $1.43 vs. LUCD: $0.40)
Brand notoriety: FEMY and LUCD are both not notable
FEMY represents the Pharmaceuticals: Other, while LUCD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: FEMY: 85% vs. LUCD: 31%
Market capitalization -- FEMY: $11.47M vs. LUCD: $76M
FEMY [@Pharmaceuticals: Other] is valued at $11.47M. LUCD’s [@Medical/Nursing Services] market capitalization is $76M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FEMY’s FA Score shows that 1 FA rating(s) are green while LUCD’s FA Score has 1 green FA rating(s).

  • FEMY’s FA Score: 1 green, 4 red.
  • LUCD’s FA Score: 1 green, 4 red.
According to our system of comparison, FEMY is a better buy in the long-term than LUCD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FEMY’s TA Score shows that 6 TA indicator(s) are bullish while LUCD’s TA Score has 5 bullish TA indicator(s).

  • FEMY’s TA Score: 6 bullish, 2 bearish.
  • LUCD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, FEMY is a better buy in the short-term than LUCD.

Price Growth

FEMY (@Pharmaceuticals: Other) experienced а +2.14% price change this week, while LUCD (@Medical/Nursing Services) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

FEMY is expected to report earnings on Nov 13, 2026.

LUCD is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+1.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and OFIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OFIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
+0.70%
OFIX - FEMY
30%
Poorly correlated
-9.87%
CSTL - FEMY
30%
Poorly correlated
+0.12%
LUCD - FEMY
30%
Poorly correlated
-4.19%
OM - FEMY
29%
Poorly correlated
+2.43%
GH - FEMY
29%
Poorly correlated
-2.17%
More

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and FEMY have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and FEMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-4.19%
FEMY - LUCD
30%
Poorly correlated
+0.70%
CNMD - LUCD
27%
Poorly correlated
-1.41%
CRL - LUCD
27%
Poorly correlated
-2.13%
BBNX - LUCD
27%
Poorly correlated
-2.54%
ELMD - LUCD
26%
Poorly correlated
+0.44%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FBY8.21-0.02
-0.24%
YieldMax META Option Income Strategy ETF (FBY)
XSPC18.16-0.07
-0.38%
VegaShares Space & AI ETF (XSPC)
ESLG27.48-0.12
-0.42%
Eventide Large Cap Growth ETF (ESLG)
PMBS47.18-0.43
-0.90%
PIMCO Mortgage-Backed Securities Active Exchange-Traded Fund (PMBS)
NVDU76.65-9.43
-10.95%
Direxion Daily NVDA Bull 2X ETF (NVDU)